DGX

Quest Diagnostics Inc.

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$15.0bn30-Sep-2610-Q filed 23-Oct-26
Remaining authorization$1.2bn30-Sep-2610-Q filed 23-Oct-26
Program expiryn/a—
Repurchased last quarter$150m30-Sep-2610-Q filed 23-Oct-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
Not found in filings$1.0bn$1.0bnESTn/aIn February 2026, our Board of Directors increased the size of our share repurchase program by $1 billion.10-Q filed 23-Oct-26
Not found in filings$14.0bn$183mESTn/aSince the share repurchase program’s inception in May 2003, our Board of Directors has authorized $14 billion of share repurchases of our common stock through September 30, 2026. The share repurchase authorization has no set expiration or termination date.10-Q filed 23-Oct-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Apr ’26
  2. May ’26
  3. Jun ’26
  4. Jul ’26
  5. Aug ’26
  6. ≈$150m
    Sep ’26
Month endedSharesWithheld & otherAvg price≈ ValueSource
30-Sep-26627,674—$238.98$150m10-Q filed 23-Oct-26
31-Aug-260——$010-Q filed 23-Oct-26
31-Jul-260——$010-Q filed 23-Oct-26
30-Jun-260——$010-Q filed 23-Jul-26
Filings through 30-Sep-26· checked 18-Nov-26